⌘K

Login Start Free

Home/Filings/4/0001209191-19-025564

4//SEC Filing

Ryali Sriram 4

Accession 0001209191-19-025564

CIK 0001305253other

View on SEC.gov Company Profile

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 9:34 PM ET

Size

4.6 KB

Accession

0001209191-19-025564

Insider Transaction Report

Form 4

Period: 2019-04-22

Eiger BioPharmaceuticals, Inc.EIGR

Chief Financial Officer

Transactions

Purchase
Common Stock
2019-04-22$11.08/sh+1,250$13,853→ 1,250 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1

filerCIK 0001762893

Filing Metadata

Form type: 4
Filed: Apr 21, 8:00 PM ET
Accepted: Apr 22, 9:34 PM ET
Size: 4.6 KB

View on SEC.gov